Intramuscular cell transplantation in humans requires so far meticulous repetitive cell injections. Performed percutaneously with syringes operated manually, the procedure is very time consuming and requires a lot of concentration to deliver the cells exactly in the required region. This becomes impractical and inaccurate for large volumes of muscle. In order to accelerate this task, to render it more precise, and to perform injections more reproducible in large volumes of muscle, we developed a specific semimanual device for intramuscular repetitive cell injections. Our prototype delivers very small quantities of cell suspension, homogeneously throughout several needles, from a container in the device. It was designed in order to deliver the cells as best as possible only in a given subcutaneous region (in our case, skeletal muscles accessible from the surface), avoiding wasting in skin and hypodermis. The device was tested in monkeys by performing intramuscular allotransplantations of β-galactosidase-labeled myoblasts. During transplantations, it was more ergonomic and considerably faster than manually operated syringes, facilitating the cell graft in whole limb muscles. Biopsies of the myoblast-injected muscles 1 month later showed abundant β-galactosidase-positive myofibers with homogeneous distribution through the biopsy sections. This is the first device specifically designed for the needs of intramuscular cell transplantation in a clinical context.
INTRODUCTION
"mesoangioblasts," and in animal models of particular muscular dystrophies (11, 12) . The experiments with intravascular-delivered mesoangioblasts created logical Transplantation of myogenic cells has several potential applications in the clinics. The most important are expectations for their potential future use in the treatment of at least some muscular dystrophies. However, it the therapeutic management of myopathies (13,21), urinary incontinence (25) , and ischemic cardiopathy (22) .
is too early to ensure that they could be useful in all kinds of muscle illness in which cell transplantation may Collaterally, transplantation of genetically modified myoblasts is considered promising for the systemic or local be helpful, to the point of leaving obsolete the intramuscular delivery of myogenic cells. delivery of hormones or factors (4,6,7,24).
In the case of myopathies, the therapeutic objectives Most of the other myogenic cells require so far direct intramuscular delivery to be efficiently incorporated into of myogenic cell transplantation are essentially the restoration of proteins whose genetic deficit causes the dis-the recipient's muscle. This is notably the case of adult myoblasts, the most frequently studied myogenic cells, ease, and, whenever possible, the restoration of contractile parenchyma in skeletal muscles wasted by a degenera-recently or presently under study in clinical trials in Duchenne (14, 15) , fascioscapular (23), and oculopha-tive disorder (13). Two different ways of cell delivery are being explored for the efficient incorporation of the ryngeal (9) muscular dystrophies, as well as in ischemic cardiopathy (22) . In addition, other types of myogenic transplanted cells into the recipient muscles: direct intramuscular implantation and intravascular injection (13).
cells more recently reported (sometimes considered as stem cells) derived or not from the skeletal muscle, re-So far, the intravascular delivery demonstrated to be efficient only using a specific type of cells named quire intramuscular implantation (1, 3, 8, 26) . The main constraint of this route of administration is that the in-ing the progression of a cell suspension from a container to several injection needles, and b) an electromechanical jected cells contribute to muscle regeneration essentially around injection trajectories, a phenomenon that is more system governing the injection sequence. We denominated the first part the hydraulic circuit, and the electro-evident in large mammals than in mice (13, 21) . To compensate this localized fusion, the surgeon needs to per-mechanical system the motor block (Fig. 1 ). It was also evident that the hydraulic system needed form meticulous equidistant injections, very close to each other, across the whole muscle, delivering the cells some essential components: a cell suspension container, a syringe for injection, several needles, a flow divisor homogeneously during each needle withdrawal. This is the method we use in nonhuman primates (10, [16] [17] [18] between the injection syringe and the needles, tubing for the circulation of the cell suspension among these parts, and myopathic patients (14, 15, 19) .
However, such a careful percutaneous cell injection and valves ensuring the direction of the flow. Once the principle to place these elements was decided ( Fig. 1B) , strategy is a slow task when done with manually operated syringes. In a clinical context, it is appropriate only the pieces were sought among those used in clinical liquid management and injection (Table 1 ). Because these for small volumes of muscle (14) . Applied throughout large volumes, the method is very time consuming, be-pieces needed to be in contact with the cell suspension, they were mainly of inert plastic. The exception was the coming strenuous and inaccurate for the permanent necessity of controlling the depth of the intramuscular cell injection syringe, made of glass and metal. We considered different cell suspension containers, including stan-delivery while avoiding cell wasting in the hypodermis. Indeed, this makes difficult to ensure reproducible cell dard injection vials, glass cartridges, and disposable syringes, either to be changed or refilled as the cell sus-injections throughout a large skeletal muscle, and the patient may endure a long session of injections.
pension was delivered. The best and simplest solution was to use a disposable syringe without the piston, leav-In order to partially alleviate these problems, we previously adapted as cell injection devices some available ing the rubber gasket closing the syringe compartment ( Fig. 1C and D, Fig. 2A ). Our prototype was designed laboratory dispensers used for the repetitive delivery of small volumes of liquid (18). One of them (a monosyr-to hold a syringe of up to 6 ml, but could be easily adapted to hold larger syringes. A 27-gauge needle in-inge dispenser) became so far our instrument of choice for myoblast transplantations in monkeys (10,18). We serted in this gasket (Figs. 1D and 2A) allowed air entry all through the cell suspension aspiration, preventing also used it for several transplantations in a myopathic patient (15) and it was used by another group in rabbits blocking of the cell suspension flow. This arrangement also allowed refilling the cell container simply by pierc-(2). However, its use in humans remains limited to relatively small regions, and the precision needed to deliver ing the rubber gasket with a syringe filled with the cell suspension ( Fig. 2A ). If the operator wanted the air en-the cells specifically in the muscle through the skin and hypodermis, together with the reproducibility of injec-tering the cell container to be filtered, the 27-gauge needle can be plugged with sterile cotton or attached to a tions, remains a challenge.
Consequently, we concluded that it would be useful 22-µm pore filter. The device was designed to use up to six standard to develop new instruments, specifically designed for the percutaneous intramuscular injection of cells in clini-disposable needles, forming a matrix of 2 × 3. Placed as close as possible, the needle are separated by ϳ8 mm. cal conditions, covering large muscles in the shortest surgical delays and ensuring reproducibility of injec-To use fewer than six needles, the nonused tips can be plugged with appropriate stoppers. The capacity of the tions. We undertook the development of this device according to the following premises: 1) cell delivery Hamilton syringe to be placed in the device can be chosen according to the number of needles to be used and through several needles at the same time; 2) cell suspension delivery in very small quantities, homogeneously the cell suspension volume to be delivered per injection trajectory (Table 2 ). Most uses would need 250-and throughout the needle trajectories; 3) cell delivery specifically in the muscle, avoiding wasting in the skin and 100-µl Hamilton syringes. We evaluated different mechanical principles to de-hypodermis; 4) minimal frequency of refilling; 5) ergonomics in the conditions of an intramuscular cell in-termine an optimal arrangement to control the injection sequence. The principle adopted was based on a small jection procedure; 6) easy to clean and to sterilize. We report here the first prototype developed with such char-Hamilton syringe injecting the cell suspension and refilling at each injection round. Thus, the device was de-acteristics. signed to perform each injection round (penetration/re-MATERIALS AND METHODS traction of the needles into the tissues) by moving down Device Conception and Fabrication and up the glass body of the Hamilton syringe, which is fixed with a screw (syringe fixation in Fig. 1A ) to a It was evident that the device needed to be designed on the basis of two parts: a) a circulatory system allow-mobile part in the motor block (mobile support in Fig.  Figure 1 . The final prototype is illustrated. The main constituents of the device assembled for use are indicated in (A) (details in Materials and Methods), while (B) shows the different pieces of the hydraulic system, (C) shows the device ready for use, and (D) illustrates the way the prototype is handled during a session of intramuscular cell transplantation in a monkey biceps (the arrow indicates the 27-gauge needle inserted in the container gasket to allow air entry throughout the cell suspension aspiration). A transparent dressing with a 5-mm grid is placed on the surgical region to control the interinjection distance. This plate helps to stabilize the needles (C) and flatten the skin surface. (D, E) Show the way to place and to remove the needles using a haemostatic forceps with curved tips. Needle removing is easier by pushing them with the curved tips of the forceps acting as a lever (E) than pulling them. The removable plate facilitates this task by maintaining the needles close to the tips before inserting them (D), and by receiving the removed needles (E), avoiding risks of injury. 1A). The mobile support, the glass body of the Hamilton ment of the needles. When the mobile support passes in front of the run-end detector, the control chip inverts the syringe, and the needles move as a whole at each injection round (Fig. 3A, B ). Syringe and needles are linked voltage applied to the motor, which turns in the opposite direction: the mobile support then moves up. This move-by a plastic support that includes the flow divisor and a "T" block connector (Fig. 1B) . The piston rod of the ment produces the needle retraction and the delivery of the cell suspension in the injection trajectories. Finally, Hamilton syringe is fixed to the nonmobile part of the motor block by another screw (piston fixation in Fig. when the mobile support passes in front of the run-start detector, the control chip cancels the voltage applied to 1A). The down and up movements of the glass part of the Hamilton syringe produce the circulation of the cell the motor and the motor stops: no movement can then occur given the self-locking nature of the lead screw. To suspension from the container towards the needles. When the mobile support moves down for needle pene-restart the sequence, the pushbutton must be released and pressed again. All motion is controlled by the logic tration, the loading valve allows aspiration of the cell suspension from the container into the Hamilton syringe, circuit included in the control chip (designed by Yves Jean and assembled by Michel Dominique, Department while the injection valve prevents reflux from the needles ( Fig. 3C ). When the mobile support moves up for of Mechanical Engineering, Laval University). To make the device as light as possible, we decided to use exter-needle retraction, the injection valve allows the delivery of the cell suspension into the injection trajectory, while nal power supply. The device is thus connected to an alternating current power socket when it is used, by the loading valve prevents reflux to the cell suspension container (Fig. 3D ).
means of a class-2 transformer. Plugging is done via a circular electric connector consisting in a cable pin and The mobile support is driven by a motor and a lead screw. To adjust the amplitude of this movement to the a panel mount placed in the back of the device, near the pushbutton ( Fig. 1A , C, D). needs of the cell delivery, a run-end detector is moved down and up through another lead screw, turning a knob An adjustable foot (a frame that surrounds the needles) is placed at the bottom of the device. This part is indicated as regulator of injection depth in Figure 1A . The position of the run-end detector determines the am-to be in contact with the skin, allowing: a) setting up the preinjection distance of the needles and b) serving as a plitude of the needle excursion. This knob also moves an indicator of injection depth (Fig. 1A) . The incursion support during the injection (Figs. 1D and 4). It can be moved vertically between 0 and 15 mm, and fixed with of the needles during the injection round can be preset between 0 and 3.5 cm. a screw, in such a manner that the distal length of the needles in the resting top position corresponds with the The motor is activated by pressing a pushbutton, placed at the bottom for a better handling by the surgeon distance needed to reach the muscle surface from the skin surface ( Fig. 4A, B ). This distance must be deter-( Fig. 1A , C, D). When the pushbutton is pressed, the motor is subjected to a voltage of 6 V, rotating clock-mined preoperatively by ultrasound analysis (Fig. 4A) .
A removable plate made of transparent plastic, with six wise and driving the lead screw through an Oldham coupling. The rotation of the lead screw allows the vertical holes corresponding to the six needles, can be fixed by pressure in the frame of the adjustable foot ( Fig. 2B, C) . motion of the mobile support. Because the piston rod of the Hamilton syringe is fixed to the device body, a This plate allows a) to stabilize the needles during the manual introduction and the motor-driven penetration of movement towards the bottom of the glass part of the syringe aspirates the cell suspension into it. The amount the needles in the tissues (Fig. 4B, C) , and b) to flatten the skin surface that otherwise can make a bulge into of solution aspirated (which will be subsequently injected) is directly proportional to the vertical displace-the frame. It also facilitates the insertion of the needles eling and Matlab (MathWorks Inc., Natick, MA) for the mathematical computation. Some pieces of the device were specifically manufactured, while others were purchased from different suppliers (Table 1) . Material for the plastic pieces supporting the mechanism and the hydraulic system was bought at Plastique Polyfab Inc.
(Quebec, QC, Canada) and then manufactured by Yvon Chalifour, from Electrotechnologies SELEM Inc. (Quebec, QC, Canada). Metal pieces such as specific screws were machined in the workshop of the Department of Mechanical Engineering at Laval University.
Measurements and Calculations
Because the device had to be as light as possible, one of the most important criteria in the choice of the mechanical components was the power-to-weight ratio. The critical components were some pieces of the hydraulic system (valves and fittings), the motor, and the gearbox. We will describe briefly the calculations made to ensure the proper functioning of these parts.
Power Losses. There were two main sources of power losses to be considered: friction losses in the hydraulic system, and friction between the needles and injected tissues. To quantify these losses, the hydraulic system was filled with a cell suspension and the piston of the Hamilton syringe was pushed with a dynamometer at about 1 cm/s (the desired speed of the system). The maximal load was ϳ200 g. This corresponded to the force necessary to overcome the friction losses in the hydraulic circuit, as well as the friction of the piston rod in the Hamilton syringe. Similar tests were performed to determine the force needed for the penetration of a needle into a tissue. A silicon bolus of radiotherapy was used in the Robotics Laboratory to simulate the injected tissues (this represented a worst case situation, because this bolus was more resistant than skin and muscle to needle penetration). For an injection speed of ϳ1 cm/s, the maximum measured force was 500 g.
Hydraulic System. The pieces of the hydraulic circuit are restrictive for pressure. To avoid leakage at the fit- pressure of the hydraulic system can be assessed by dividing the maximum force applied to the piston rod by the diameter of the rod. For a 250-µl Hamilton syringe, in the device, because the needles can be placed first in this was: the plate and approached close to the tips before inserting them (Fig. 2D ). It also facilitates to remove the nee-
× (2.2lbs/kg) = 67.7psi dles that can be collected in the plate before being securely discarded (Fig. 2E) .
In order to verify the concept and to guide the design, Because the maximum pressure that can be achieved we performed simulations with the following software: is much lower than the limits of the pieces of the hy-Pro/ENGINEER (PTC, Needham, MA) for the 3D mod- Figure 4 . The operation of the device is illustrated. According to an ultrasound analysis of the region to be injected (A), the operator sets the adjustable foot to leave the needle length necessary to go through the skin and hypodermis, and sets the incursion distance of the needles into the muscle by turning the regulator of injection depth. The operator introduces the needles until the device's foot touches the skin surface (B). At that moment, the needles' tips may be placed at the muscle surface. Pressing the pushbutton (arrowheads), the needles penetrate the muscle (C) and the syringe is filled with the cell suspension. Once the needles reach the depth of injection (C), they are automatically retracted to their original position and stop (D). The cells are homogeneously delivered during this retraction (D). The operator withdraws manually the needles (E) and restarts the sequence following the planned interinjection distance. Arrows indicate the manual (gray) and motor-driven (black) movements. draulic system, the system was expected to work cor-
Motor and Gearbox.
= 378 t rpm Power Losses. The choice of the motor depends on the friction forces to be countered. The motor must over-Therefore, for trajectory times ranging from 1 to 1.5 come the friction of six needles penetrating the muscle s, the desired speed of the motor must be between 252 (6 × 0.5 kg = 3 kg), as well as the friction losses in the and 378 rpm. hydraulic system (200 g). The sum of the two, with a Selection of Motor, Gearbox, and Control Chip. These safety factor of 2, gives a maximum external force to calculations were used to choose a combination motor/ counter of 6.4 kg or 62.8 N (14.1 lbs). gearbox/chip appropriate for the required performance Torque. The sum of these external forces is exerted on in terms of torque and speed of operation. Their most the mobile support, which progresses through a lead important characteristics are presented in Table 3 . From screw (16 threads per inch) using a Supernut. The couthis table it can be noted the following. ple T d to be applied to this screw to generate a force of In order to avoid excessive heat, the maximum cur-14.1 lbs was calculated taking into account the force P, rent from the chip I chip is selected to be equal to the conthe thread of the screw L, and the efficiency h f of the tinuous current of the selected motor I cont . Then, the max-Supernut:
imum torque of the motor/gearbox/chip block is: T max block = T cont mot × r gearbox × h gearbox = 0.061 Nm). The expected torque (T d = 0.033 Nm) is sufficiently lower than the latter torque.
The maximum torque of the motor/gearbox/chip = 0.29lbs ؒ in = 0.033Nm block (T max block = 0.061 Nm) is sufficiently lower than the maximum torque that can be sustained by the gearbox (T max gearbox = 0.225 Nm). Rotational Speed. The rotational speed w d of the motor (for a given torque) depends on the range of motion d x The chip voltage (V chip = 6 V) is selected as half the of the mobile block, the time t required for this movenominal voltage (V nom = 12 V) in order to obtain a speed ment, and the thread L of the screw: of the motor, which is half the no-load speed (w empty mot = 13900 rpm). With the selected gearbox ratio, the result-1 medium with 15% fetal bovine serum (Valley Biomedical, Winchester, VA) and 10 ng/ml of basic fibro-ing speed of the motor/gearbox/chip block is: w empty block = (w empty mot /2) × (1/r gearbox ) = 366 rpm, which is in the de-blast growth factor (Wisent, St-Bruno, QC, Canada). They were infected in vitro with a retroviral vector encoding sired range of speed.
Half of the no-load speed (6950 rpm) is below the the LacZ gene (gift from Dr. C. Cepko, Harvard University, Boston, MA). For transplantations, the cells were allowable limit at the gearbox input (w input = 8000 rpm).
It can be shown that the run speed of the mobile sup-resuspended in a balanced salt solution into a 10-ml vial. The cell suspension container in the device was filled port is 0.97 cm/s (@366 rpm) if no force is applied, and 0.83 cm/s if the external force reaches the maximum with the content of these vials. Transplantations were done throughout one biceps brachii by parallel cell in-value T d = 0.033 Nm (@312 rpm). The injector will have then a speed of operation around the desired value jections, trying to maintain 1 mm of distance between each other. In one monkey, myoblast transplantations of 1 cm/s. were done in two other sites using either a manually In Vivo Tests in Nonhuman Primates operated 50-µl Hamilton syringe (16) or a PB600-1 repeating dispenser with a 250-µl syringe (18). Although We tested the device performing intramuscular myoblast allotransplantations in six adult cynomolgus mon-different instruments were used, the transplantation parameters (cells, interinjection distance, amount of cells keys (Macaca fascicularis). The two first monkeys were used to practice the technique of injection and to plan per injection, needle size) were similar. One month posttransplantation, we took samples of adjustments in the device, while the other four monkeys were used to quantify the results of the transplantation.
the cell-transplanted muscles of the monkeys. Euthanasia was done in one monkey to sample the entire biceps The use of the device was innovative, but the rest of the procedure was similar to our standard transplantation brachii. Muscle samples (including a whole biceps brachii) were mounted in embedding medium, frozen in protocol in monkeys (16) (17) (18) . Briefly, transplantations and biopsies were done under general anesthesia with liquid nitrogen, and serial sections of 10-15 µm were made in a cryostat. β-Galactosidase-positive myofibers isofluorane. Ketoprofen was given for postoperative analgesia. Tacrolimus (a generous gift from Fujisawa were revealed in the muscle sections with X-Gal, as previously described (5) and analyzed in a microscope. Pharmaceutical Co., Ltd., Osaka, Japan) was used for immunosuppression. Euthanasia was done in two mon-Cell suspensions were also prepared for ex vivo tests (i.e., evaluation of the cell mortality after passage keys by intracardiac overdose of sodium pentobarbital after ketamine anesthesia. All procedures were autho-through the device and evaluation of the cell suspension distribution among the six needles). For both transplan-rized by the Laval University Animal Care Committee.
Myoblasts from muscle biopsies were grown in MB-tations and ex vivo tests, the cell suspension concentra-tion was between 28 × 10 6 and 57 × 10 6 cells/ml (i.e., position (provided that air in the cell container does not enter into the hydraulic circuit). The procedure of cell over the optimal for myoblast transplantation experiments in monkeys, which is about 20 × 10 6 cells/ml for injection was considerably faster, less tiring and more ergonomic than using manually operated syringes. the injection parameters used).
The muscle samples taken 1 month posttransplanta-RESULTS tion in the sites grafted with the semimanual device showed β-galactosidase-positive myofibers homoge-The final prototype performed well and reached the objectives set out before the design, essentially as indi-neously distributed throughout the muscle sections, and sometimes better than in sites grafted with manual pro-cated below.
The device can deliver a cell suspension through six cedures in the same monkey (Fig. 6A, B) . The transplantation success (51-63% of β-galactosidase-positive my-needles (or fewer if desired) at the same time. By testing the device ex vivo, the volume of liquid delivered per ofibers in the muscle cross-sections) was in the superior region of the range obtained with our manual procedures needle was equivalent (Fig. 5 ). This was similar when using only water or a cell suspension at the standard (Fig. 6C ). concentration used for an optimal transplantation. It was Practical Considerations impossible to quantify the volume delivered per needle in vivo, but when reflux of injected cell suspension was
The device needs to be properly set up prior to each transplantation session, which requires being familiar produced deliberately there was always a similar drop of cell suspension emerging at each injection point.
with the sequence of preparation. This includes filling the dead space of the hydraulic circuit with saline solu-The cell suspension circulates well and follows the expected direction and sequence. There is no leakage or tion before loading the cell suspension, to ensure that no bubbles remain within and that liquid circulation is air entry at the fittings. The speed of the needles is of around 1 cm/s. appropriate. A bubble remaining in the plastic hub of a needle was sometimes enough to block liquid delivery The trypan blue tests performed with the cell suspension before and after passage through the device showed through this needle during tests ex vivo, although apparently not during in vivo injections. Then, when the cell no increase of cell death (1.7% of cell death before passage and 1.9% after passage in one test, and 6% before suspension is loaded in the container, the operator needs to perform several injection rounds ex vivo to allow the passage and 5.3% after passage in another test).
The device has a weight of 400 g. It can be comfort-cell suspension to replace the saline solution into the hydraulic circuit. The tubing in the hydraulic system is ably handled during the transplantation session, and can function either in a vertical, inclined, or even horizontal transparent and allows observing the progression of the cloudy and colored cell suspension pushing the hyaline saline solution. The dead space of the hydraulic system, from the tip of the cell suspension container until the tips of the injection needles (excluding the Hamilton syringe) is of roughly 1 ml. In addition, some training is needed to properly place the device at each injection round to reach a homogeneous cell delivery throughout the muscle.
Some cell sedimentation can occur in the cell suspension container during transplantation. To resuspend the cells, it is sufficient to tilt the device allowing the air into the cell suspension container to form a bubble stirring the liquid by its passage.
Pauses during transplantation may be essentially to refill the cell suspension container and to change the needles. Refilling must be done while there is still some cell suspension into the container to avoid passage of air Figure 5 . Percentage of the total content of the cell suspension into the hydraulic circuit. Thus, the surgeon must monicontainer delivered per needle into small tubes, following three tor the level of liquid into the container. Refilling is tests with either water or cell suspension. Needles were 25rapid and easy ( Fig. 2A) . We performed cell injections gauge 1.5 inches, and the indicator of injection depth was adthroughout monkey biceps without changing the neejusted at 3 cm; cell suspension concentration was 40 × 10 6 cells/ml. dles, but this may be needed in larger surfaces. To avoid Figure 6 . Results of transplanting β-galactosidase-labeled myoblasts in monkeys, using our manual techniques versus the semimanual device. Two cross-sections of biceps brachii biopsies obtained 1 month posttransplantation in a monkey and histochemically treated to reveal β-galactosidase-positive (β-Gal+) myofibers are illustrated (A, B). The main transplantation parameters were similar in both sites (cells, interinjection distance, amount of cells per injection, needle size) but injections were done either manually using a repeating dispenser with a Hamilton syringe or with the semimanual device. The semimanual device gave in this case more homogeneous results in terms of density and distribution of β-galactosidase-positive myofibers. The arrow on the left indicates the direction of the cell injection trajectories. Scale bar: 1 mm (applies to both images). (C) The graphic shows a comparison of the results obtained in the four monkeys grafted here with the semimanual device, and a pool of 14 results obtained here or previously in monkeys grafted manually, using similar parameters of transplantation (needle size, interinjection distance, optimal amounts of cells, appropriate immunosuppression). accidental injury, the needles can be detached and placed tions throughout large skeletal muscles. This device was designed to solve some of the most important problems using haemostatic forceps, preferably with curved tips (Fig. 2D, E) . Removing the needles is faster and easier encountered in our clinical practice of intramuscular cell transplantation. After years of experience on myogenic by pushing them from the tips than pulling them ( Fig. 2E ).
cell transplantation in nonhuman primates (16) (17) (18) 20) , Safety Issues and following our recent human tests (14, 15, 19) , we concluded on the importance of creating specific instru-To complete the injection round, the pushbutton needs to be maintained pressed. Releasing the button ments for this task, allowing efficient cell transplantations throughout large skeletal muscles in the shortest stops the needle movement in the case of an undesired event. The needle movement can then be resumed by surgical delays. We analyzed different mechanical principles for this pressing the same button. device. A first principle was based on the repeating dis-Cleaning and Sterilization penser that we used for myoblast transplantation in nonhuman primates and in a patient (10,15,18 ). The idea The hydraulic circuit can be easily detached from the motor block and disassembled for appropriate cleaning was then a device holding a large Hamilton syringe, refilled entirely from a cell suspension container, and em-and sterilization. All the pieces of the hydraulic circuit can be immersed in disinfectant solutions. Pressure air pting its content progressively at each injection round, a pause being needed to refill the syringe before continu-is useful to dry these pieces before sterilization. With the exception of the device's foot (that can be detached) ing with the next series of injections. This idea was abandoned for the present design, in which a smaller the motor block cannot be immersed, but its plastic surface can be cleaned with gauze soaked in a disinfectant
Hamilton syringe delivers the cell suspension and refills at each injection round, until the cell suspension con-solution. All components can be sterilized with ethylene oxide.
tainer is empty. This design has some advantages over the former, namely: a) the overall mechanism was sim-DISCUSSION plified; b) the cell suspension circulates continuously, helping to avoid cell sedimentation in the tubing, con-We described a first device specifically designed to perform repetitive percutaneous intramuscular cell injec-nectors and valves, as could happen during the long
